Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 666Generated: October 28, 2026

1-Methylpiperazine → 1-(4-Chloro-2-methoxyphenyl)-4-methylpiperazine

https://huagongshe.com/reaction/666

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-MethylpiperazineHCID 53167—
Reactant4-Chloro-1-iodo-2-methoxybenzeneHCID 16079230—
ReagentSodium t-butoxideHCID 23676156—
Catalyst1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
CatalystPalladium (II) acetateHCID 4144353—
SolventTolueneHCID 1140—
Product1-(4-Chloro-2-methoxyphenyl)-4-methylpiperazineHCID 11908719563.57%

Reaction Conditions

Temperature100 °C

Reaction Steps

Palladium II acetate (25.09 mg, 0.11 mmol) was added to 4-chloro-1-iodo-2-methoxybenzene (300 mg, 1.12 mmol), 1-methylpiperazine (0.124 ml, 1.12 mmol), sodium 2-methylpropan-2-olate (215 mg, 2.23 mmol) and 9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene (323 mg, 0.56 mmol) in toluene (4 ml) at room temperture under nitrogen. The resulting mixture was stirred at 100oC overnight. The reaction mixture was filtered through celite and then concentrated under reduced pressure. The crude product was then taken up in DCM and washed with water. The crude product was purified by chromatography in DCM:MeOH 0-->10% to afford 1-(4-chloro-2-methoxyphenyl)-4-methylpiperazine (171 mg, 63.6 %) as yellow oil. This was carried through to the next reaction immediately as it is a controlled substance.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-890c9e12800b48cca35bf6f2a67a4cca
Source note750 AstraZeneca ELN dataset